Highlights in Chronic Lymphocytic Leukemia From the 60th American Society of Hematology Annual Meeting: Commentary

被引：0
作者：
O'Brien, Susan M. [1 ,2 ,3 ]
机构：
[1] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Clin Sci, Orange, CA 92668 USA
[2] Univ Calif Irvine, Sue & Ralph Stern Ctr Clin Trials & Res, Orange, CA 92668 USA
[3] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Med, Orange, CA 92668 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 01期
关键词：
CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB; CHEMOIMMUNOTHERAPY; IBRUTINIB; THERAPY; CLL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 23
页数：4
相关论文
共 16 条
[1]   Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2 [J].
Barr, Paul M. ;
Robak, Tadeusz ;
Owen, Carolyn ;
Tedeschi, Alessandra ;
Bairey, Osnat ;
Bartlett, Nancy L. ;
Burger, Jan A. ;
Hillmen, Peter ;
Coutre, Steven ;
Devereux, Stephen ;
Grosicki, Sebastian ;
McCarthy, Helen ;
Li, Jianyong ;
Simpson, David ;
Offner, Fritz ;
Moreno, Carol ;
Zhou, Cathy ;
Styles, Lori ;
James, Danelle ;
Kipps, Thomas J. ;
Ghia, Paolo .
HAEMATOLOGICA, 2018, 103 (09) :1502-1510
[2]   Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia [J].
Burger, J. A. ;
Tedeschi, A. ;
Barr, P. M. ;
Robak, T. ;
Owen, C. ;
Ghia, P. ;
Bairey, O. ;
Hillmen, P. ;
Bartlett, N. L. ;
Li, J. ;
Simpson, D. ;
Grosicki, S. ;
Devereux, S. ;
McCarthy, H. ;
Coutre, S. ;
Quach, H. ;
Gaidano, G. ;
Maslyak, Z. ;
Stevens, D. A. ;
Janssens, A. ;
Offner, F. ;
Mayer, J. ;
O'Dwyer, M. ;
Hellmann, A. ;
Schuh, A. ;
Siddiqi, T. ;
Polliack, A. ;
Tam, C. S. ;
Suri, D. ;
Cheng, M. ;
Clow, F. ;
Styles, L. ;
James, D. F. ;
Kipps, T. J. ;
Keating, Michael ;
Jen, Jie ;
Jindra, Pavel ;
Simkovic, Martin ;
Braester, Andrei ;
Ruchlemer, Rosa ;
Foa, Roberto ;
Semenzato, Gianpietro ;
Hawkins, Timothy ;
Atanasio, Carolina Moreno ;
Demirkan, Fatih ;
Kaynar, Leylagul ;
Pylypenko, Halyna ;
Fox, Christopher ;
Thirman, Michael ;
Campbell, Philip .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) :2425-2437
[3]   Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia [J].
Burger, Jan A. ;
Sivina, Mariela ;
Jain, Nitin ;
Kim, Ekaterina ;
Kadia, Tapan ;
Estrov, Zeev ;
Nogueras-Gonzalez, Graciela M. ;
Huang, Xuelin ;
Jorgensen, Jeffrey ;
Li, Jianling ;
Cheng, Mei ;
Clow, Fong ;
Ohanian, Maro ;
Andreeff, Michael ;
Mathew, Thomas ;
Thompson, Philip ;
Kantarjian, Hagop ;
O'Brien, Susan ;
Wierda, William G. ;
Ferrajoli, Alessandra ;
Keating, Michael J. .
BLOOD, 2019, 133 (10) :1011-1019
[4]   Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study [J].
Chanan-Khan, Asher ;
Cramer, Paula ;
Demirkan, Fatih ;
Fraser, Graeme ;
Silva, Rodrigo Santucci ;
Grosicki, Sebastian ;
Pristupa, Aleksander ;
Janssens, Ann ;
Mayer, Jiri ;
Bartlett, Nancy L. ;
Dilhuydy, Marie-Sarah ;
Pylypenko, Halyna ;
Loscertales, Javier ;
Avigdor, Abraham ;
Rule, Simon ;
Villa, Diego ;
Samoilova, Olga ;
Panagiotidis, Panagiots ;
Goy, Andre ;
Mato, Anthony ;
Pavlovsky, Miguel A. ;
Karlsson, Claes ;
Mahler, Michelle ;
Salman, Mariya ;
Sun, Steven ;
Phelps, Charles ;
Balasubramanian, Sriram ;
Howes, Angela ;
Hallek, Michael ;
Assouline, S. ;
Bence-Bruckler, I. ;
Buckstein, R. ;
Fraser, G. ;
Larratt, L. ;
Minuk, L. ;
Villa, D. ;
Angevine, A. ;
Bartlett, N. ;
Bixby, D. ;
Caimi, P. ;
Chanan-Khan, A. ;
Craig, M. ;
Forero-Torres, A. ;
Ganguly, S. ;
Goy, A. ;
Heffner, L. ;
Hermann, R. ;
Lansigan, F. ;
Leis, J. ;
Letzer, J. .
LANCET ONCOLOGY, 2016, 17 (02) :200-211
[5]   First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial [J].
Eichhorst, Barbara ;
Fink, Anna-Maria ;
Bahlo, Jasmin ;
Busch, Raymonde ;
Kovacs, Gabor ;
Maurer, Christian ;
Lange, Elisabeth ;
Koeppler, Hubert ;
Kiehl, Michael ;
Soekler, Martin ;
Schlag, Rudolf ;
Vehling-Kaiser, Ursula ;
Koechling, Georg ;
Ploeger, Christoph ;
Gregor, Michael ;
Plesner, Torben ;
Trneny, Marek ;
Fischer, Kirsten ;
Doehner, Harmut ;
Kneba, Michael ;
Wendtner, Clemens-Martin ;
Klapper, Wolfram ;
Kreuzer, Karl-Anton ;
Stilgenbauer, Stephan ;
Boettcher, Sebastian ;
Hallek, Michael .
LANCET ONCOLOGY, 2016, 17 (07) :928-942
[6]   Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial [J].
Fischer, Kirsten ;
Bahlo, Jasmin ;
Fink, Anna Maria ;
Goede, Valentin ;
Herling, Carmen Diana ;
Cramer, Paula ;
Langerbeins, Petra ;
von Tresckow, Julia ;
Engelke, Anja ;
Maurer, Christian ;
Kovacs, Gabor ;
Herling, Marco ;
Tausch, Eugen ;
Kreuzer, Karl-Anton ;
Eichhorst, Barbara ;
Boettcher, Sebastian ;
Seymour, John F. ;
Ghia, Paolo ;
Marlton, Paula ;
Kneba, Michael ;
Wendtner, Clemens-Martin ;
Doehner, Hartmut ;
Stilgenbauer, Stephan ;
Hallek, Michael .
BLOOD, 2016, 127 (02) :208-215
[7]   Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions [J].
Goede, Valentin ;
Fischer, Kirsten ;
Busch, Raymonde ;
Engelke, Anja ;
Eichhorst, Barbara ;
Wendtner, Clemens M. ;
Chagorova, Tatiana ;
de la Serna, Javier ;
Dilhuydy, Marie-Sarah ;
Illmer, Thomas ;
Opat, Stephen ;
Owen, Carolyn J. ;
Samoylova, Olga ;
Kreuzer, Karl-Anton ;
Stilgenbauer, Stephan ;
Doehner, Hartmut ;
Langerak, Anton W. ;
Ritgen, Matthias ;
Kneba, Michael ;
Asikanius, Elina ;
Humphrey, Kathryn ;
Wenger, Michael ;
Hallek, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12) :1101-1110
[8]  
JAIN N, 2018, BLOOD S1, V132
[9]  
Kim E, 2014, BLOOD, V124
[10]  
Moreno C, 2018, BLOOD S1, V132
12